The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Introgen Therapeutics, Inc.

Introgen Therapeutics, Inc.
Nasdaq: INGN
Change
symbol:
     
 PROFILE
Introgen Therapeutics' gene therapy products fight cancer by attempting to restore or correct missing or aberrant gene functions. Working with Aventis, the company is testing its flagship product, INGN 201, as a treatment for head and neck cancer. Introgen also has a research agreement with the National Cancer Institute to conduct clinical studies of INGN 201 for other cancers. In addition to INGN 201, the firm is researching genetic products for treating breast, lung, colorectal, prostate, and other cancers. The company has established a presence in Europe through subsidiary Gendux AB to enhance its connections there. Aventis owns about 20% of the company.

 COMPETITION
Onyx Pharmaceuticals, Inc. (ONXX)
Valentis, Inc. (VLTS)
Vical Incorporated (VICL)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: June
2000 Sales (mil.): 8.40
1-Yr. Sales Growth: 2.6%
Employees: 53
Revenue per employee: $158,490.57

 KEY PEOPLE
• David G. Nance
    CEO
• James W. Albrecht
    CFO

 CONTACT INFO
301 Congress Ave., Ste. 1850
Austin, TX 78701
US
Phone: 512-708-9310
Fax: 512-708-9311
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001